A Randomized Trial of Alvimopan for the Reduction of Ileus After Long Posterior Spinal Fusion
Phase of Trial: Phase II
Latest Information Update: 20 May 2019
Price : $35 *
At a glance
- Drugs Alvimopan (Primary)
- Indications Postoperative ileus
- Focus Therapeutic Use
- 25 Mar 2019 Status changed from active, no longer recruiting to completed.
- 23 Jul 2018 Planned End Date changed from 1 May 2018 to 1 Dec 2018.
- 23 Jul 2018 Planned primary completion date changed from 1 May 2018 to 1 Dec 2018.